MedTrace Logo

Modulation of Gut Microbiota by Probiotic in Children With Respiratory Symptoms

NCT05794815 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-08-22

No results posted yet for this study

Summary

This project aims to study the benefits of probiotics namely Bifidobacterium infantis YLGB-1496 in modulating gut microbiota of children with respiratory symptoms, among pre-school children in Malaysia aged \>12 months old, \<7 years old.

Conditions

  • Respiratory Infection (for Example, Pneumonia, Bronchitis)

Interventions

DIETARY_SUPPLEMENT

Probiotic

Bifidobacterium infantis YLGB-1496 at 1x10 log CFU/day for 12 weeks

DIETARY_SUPPLEMENT

Placebo

Intervention consists of daily administration of 2g of maltodextrin, administered daily for 12-weeks)

Sponsors & Collaborators

  • National University of Malaysia

    collaborator OTHER

  • Min-Tze LIONG

    lead OTHER

Principal Investigators

  • Adli Ali, MD · National University of Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2026-05-01
Completion
2026-05-01

Countries

  • Malaysia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05794815 on ClinicalTrials.gov